Learn, experience and procure at INTERPHEX 2018

INTERPHEX has supported more than 20 North American and worldwide technology launches. In 2017, the show saw an increase in total attendance with 47 percent attending for the first time.

Bio/pharma engineers, engineers and international professionals also increased in attendance.

Developed by Pharmaceutical Technology and INTERPHEX, the show will feature a comprehensive, two-day keynote series with industry experts who will deliver insight on key industry themes. Session tracks include: Continuous Manufacturing; Quality Metrics & Systems; Formulation & Stability; Manufacturing Efficiencies & Improvements; Optimizing Facilities through Innovation & Technologies; Risk Management; and CMO/CDMOs: A Competitive Advantage.

INTERPHEX Live is the show’s technical education program. It is expanded this year to feature hot topics presented by industry experts. Programs are included such as "Automation Trends Facing the Industry" by Peter Zornio, chief technology officer for Emerson Automation Solutions; "Emerging and Transformational Technologies in Personalized Medicine — A Paradigm Shift" by Katey Worrilow, Ph.D., of LifeAire; and "Biosimilars 4.0" by Mani Krishnan, VP technical services & scientific affairs for Pall Corporation and Michiel E. Ultee, Ph.D., principal of Ulteemit BioConsulting.

New this year is FormulationX, which will bring leading drug substance suppliers and key decision-makers together to help meet the needs of the North American market and drug substance industry.

"FormulationX was designed to meet the needs of the North American market and drug substance industry professionals," said Melissa Ashley, senior vice president of INTERPHEX. "Pharmaceutical and biotechnology companies around the world expect an increase in spend for raw materials, excipients, intermediates, fine chemicals and API in the coming years due to the increasing demand for new drugs, innovation in excipients and new technologies used in manufacturing."

FormulationX will feature exhibits, a technical conference and networking focused on drug substances. Elsevier, a leading information analytics company specializing in science and health, will serve as a Foundation Sponsor. Elsevier is a long-established organization recognized as a key resource in helping progress science, advance health care and improve performance. The collaboration aligns with the goals of both organizations to offer firsthand access to the latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle. The goal is to help the research community make discoveries, collaborate with industry colleagues and share insight to expand the boundaries of knowledge and intelligence.

Also new for 2018 is a dedicated space for pharmaceutical and biopharmaceutical contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMO). Pharma and Biopharma Outsourcing Association (PBOA), a nonprofit trade association that represents the regulatory, legislative and general business interests of CMOs and CDMOs will sponsor the space.

"Our support and involvement in INTERPHEX underscores our commitment to expand and advance our members’ and the global community’s knowledge-base at this leading industry forum," said Gil Roth, PBOA president. "There is a strong alignment between our organizations to share cutting-edge insight, innovation and technical expertise with industry professionals who attend INTERPHEX."

Visit the Process Flow Network at Booth 1109.